Legal Representation
Attorney
Connie Ellerbach
USPTO Deadlines
Next Deadline
101 days remaining
NOA E-Mailed - SOU Required
Due Date
October 29, 2025
Extension Available
Until April 29, 2026
Application History
12 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Apr 29, 2025 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Mar 4, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Mar 4, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Feb 26, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Feb 6, 2025 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Feb 6, 2025 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Feb 6, 2025 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Feb 6, 2025 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Feb 6, 2025 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Feb 5, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Feb 4, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jul 15, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Vaccines; vaccine preparations; medical preparations for the treatment of autoimmune diseases, infectious diseases, respiratory diseases, mucosal diseases, multiple sclerosis, type 1 diabetes; pharmaceutical preparations and substances for the treatment of autoimmune diseases, infectious diseases, respiratory diseases, mucosal diseases, multiple sclerosis, type 1 diabetes; chemical preparations for pharmaceutical or medical purposes, namely, for the treatment of diseases affecting mucosal tissues, the immune system, respiratory tissues; chemical preparations for pharmaceutical purposes, namely, for autoimmune diseases, infectious diseases, respiratory diseases, mucosal diseases, multiple sclerosis, type 1 diabetes; chemical preparations for medical purposes, namely, for autoimmune diseases, infectious diseases, respiratory diseases, mucosal diseases, multiple sclerosis, type 1 diabetes
Class 042
Research and development of vaccines; research and development of medicines; medical research; scientific research; clinical research; all in the field of autoimmune diseases, infectious diseases, respiratory diseases, mucosal diseases, multiple sclerosis, type 1 diabetes, immunotherapy
Class 044
Medical services; medical testing for treatment purposes; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical evaluation services of autoimmune diseases, infectious diseases, respiratory diseases, mucosal diseases, multiple sclerosis, type 1 diabetes; medical treatment of autoimmune diseases, infectious diseases, respiratory diseases, mucosal diseases, multiple sclerosis, type 1 diabetes
Additional Information
Pseudo Mark
MACH ONE
Classification
International Classes
005
042
044